FORA Capital’s Agilon Health AGL Stock Holding History

FORA Capital’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,758	Closed	-$299K	–	488
2025 Q1	$299K	Buy	+2,758	New	+$240K	0.03%	399

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

FORA Capital's AGL Position: Q2 2025 in Review

FORA Capital sold out of Agilon Health (AGL) in Q2 2025, closing a stake of 2,758 shares — an estimated $299K sold.

FORA Capital first reported a position in AGL in Q1 2025 and held it in 1 quarter. The position peaked at $299K in Q1 2025. 205 funds tracked by Wall St. Rank hold AGL as of Q2 2025.

FORA Capital reported no remaining Agilon Health position as of Q2 2025 after selling out during the quarter.
FORA Capital sold 2,758 Agilon Health shares in Q2 2025, an estimated $299K.
FORA Capital first reported a position in Agilon Health in Q1 2025 and held it in 1 quarter.
FORA Capital's Agilon Health position peaked at $299K in Q1 2025.
205 funds tracked by Wall St. Rank held Agilon Health as of Q2 2025.

Based on FORA Capital's 13F filing for Q2 2025, filed 13 Aug 2025.